Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair?

Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair?

Bibliographic Details
Main Author:	Swiss Medical Weekly
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2003-07-01
Series:	Swiss Medical Weekly
Subjects:	Alveolar repair Pulmonary fibrosis idiopathic pulmonary fibrosis
Online Access:	https://www.smw.ch/index.php/smw/article/view/289

Similar Items

The Role of Hippo/YAP Signaling in Alveolar Repair and Pulmonary Fibrosis
by: Jason J. Gokey, et al.
Published: (2021-10-01)

Idiopathic pulmonary fibrosis: current diagnosis and treatment
by: Alexandre Franco Amaral, et al.
Published: (2023-08-01)

New Perspectives on the Aberrant Alveolar Repair of Idiopathic Pulmonary Fibrosis
by: Zhao Ni Wang, et al.
Published: (2020-09-01)

Circular RNAs and their roles in idiopathic pulmonary fibrosis
by: Akshaya Surendran, et al.
Published: (2024-02-01)

Towards a better diagnosis of idiopathic pulmonary fibrosis
by: D. Valeyre
Published: (2011-06-01)

Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
by: Roxana-Elena Cîrjaliu, et al.
Published: (2023-06-01)

Idiopathic Pulmonary Fibrosis and Telomeres
by: Alba Mulet, et al.
Published: (2022-11-01)

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
by: Qianru Mei, et al.
Published: (2022-01-01)

Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
by: Wei Yan, et al.
Published: (2015-01-01)

Heterogeneity in Fibroblast Proliferation and Survival in Idiopathic Pulmonary Fibrosis
by: David Michael Habiel, et al.
Published: (2014-01-01)

Mortality from idiopathic pulmonary fibrosis: a temporal trend analysis in Brazil, 1979-2014
by: Eduardo Algranti, et al.

Dysregulated cross-talk between alveolar epithelial cells and stromal cells in idiopathic pulmonary fibrosis reduces epithelial regenerative capacity
by: Marissa Wisman, et al.
Published: (2023-08-01)

Comorbidities and Complications in Idiopathic Pulmonary Fibrosis
by: Esteban Cano-Jiménez, et al.
Published: (2018-08-01)

The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis
by: Jiahui Zhu, et al.
Published: (2022-11-01)

Growth factors in idiopathic pulmonary fibrosis: relative roles
by: Allen Jeremy T, et al.
Published: (2001-11-01)

Reciprocal interactions between alveolar progenitor dysfunction and aging promote lung fibrosis
by: Jiurong Liang, et al.
Published: (2023-06-01)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
by: Paschalis Ntolios, et al.
Published: (2021-04-01)

Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
by: Steven D. Nathan, et al.
Published: (2024-01-01)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
by: Justin M. Oldham, et al.
Published: (2017-08-01)

TRIM72 promotes alveolar epithelial cell membrane repair and ameliorates lung fibrosis
by: Xiaofei Cong, et al.
Published: (2020-05-01)

Clinical course and management of idiopathic pulmonary fibrosis
by: Caitlin Quinn, et al.
Published: (2019-12-01)

Prognostic impact of the ratio of the main pulmonary artery to that of the aorta on chest computed tomography in patients with idiopathic pulmonary fibrosis
by: Ji Soo Choi, et al.
Published: (2019-04-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
by: Maria S. Nashatyreva, et al.
Published: (2023-01-01)

Composition and modification of the lung microbiome in patients with idiopathic pulmonary fibrosis
by: Victoria Maria Ruta, et al.
Published: (2020-10-01)

Benefits of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Drug Treatment
by: Yuji Iwanami, et al.
Published: (2022-09-01)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
by: Spagnolo Paolo, et al.
Published: (2012-11-01)

NHLRC2 expression is increased in idiopathic pulmonary fibrosis
by: Mervi Kreus, et al.
Published: (2022-08-01)

Exacerbation of idiopathic pulmonary fibrosis
by: S. N. Avdeev, et al.
Published: (2020-03-01)

Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
by: Filippo Patrucco, et al.
Published: (2023-03-01)

Association between timing of intubation and mortality in patients with idiopathic pulmonary fibrosis
by: Eunhye Bae, et al.
Published: (2022-11-01)

Activated MC<sub>TC </sub>mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis
by: Löfdahl Claes-Göran, et al.
Published: (2011-10-01)

Comparative study between pirfenidone and traditional drugs in treatment of idiopathic pulmonary fibrosis
by: Ramadan M Nafee, et al.
Published: (2019-01-01)

The impact of emphysema in pulmonary fibrosis
by: Vincent Cottin
Published: (2013-06-01)

Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
by: Yihang Zhang, et al.
Published: (2023-01-01)

The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review
by: Claudio Tirelli, et al.
Published: (2022-12-01)

Value of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
by: Nizar Rifaat, et al.
Published: (2014-10-01)

Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
by: Francesco Salton, et al.
Published: (2019-03-01)

Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension
by: Dalia D. Hadi, et al.
Published: (2023-11-01)

Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
by: Amarpreet Kaur, et al.
Published: (2017-09-01)

Herbal Remedies Effective on Treating Idiopathic Pulmonary Fibrosis
by: Aditi Chaudhary, et al.
Published: (2023-12-01)